Trial Profile
Safety and Efficacy Study of Sorafenib in Japanese Child-Pugh A and B Patients with Advanced Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Jan 2016 Results published in the Investigational New Drugs
- 14 Oct 2015 Results published in the Investigational New Drugs
- 20 Dec 2011 New trial record